Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis (Q42715750)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis |
scientific article |
Statements
1 reference
Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis (English)
1 reference
Ruth Tal-Singer
1 reference
Richard B Moss
1 reference
Sunil J Mistry
1 reference
Michael W Konstan
1 reference
Joseph M Pilewski
1 reference
Eitan Kerem
1 reference
Aili L Lazaar
1 reference
CF2110399 Investigators
1 reference
17 September 2012
1 reference
1 reference
Identifiers
1 reference